Adjuvant immunotherapy versus tyrosine kinase inhibitors in patients with high-risk renal cell carcinoma: A systematic review and network meta-analysis of oncologic and toxicity outcomes

Authors :: P.I. Karakiewicz
Fahad Quhal
K. Mori
S.F. Shariat
Hadi Mostafaei
Pawel Rajwa
Takafumi Yanagisawa
Jeremy Yuen-Chun Teoh
Manuela Schmidinger
D. Enikeev
E. Laukhtina
Satoshi Katayama
Abdulmajeed Aydh
Frederik König
B. Pradere
Nico С. Grossmann
R. Sari Motlagh
Source :: European Urology Open Science. 33:S333-S334
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Urology
medicine.medical_treatment
Immunotherapy
medicine.disease
Renal cell carcinoma
Internal medicine
Meta-analysis
Toxicity
medicine
In patient
business
Adjuvant
Tyrosine kinase

Full Text Access

Tools